AlphaMadera's AlphaVal page computes Rosinbomb's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag ROSN as undervalued, fairly valued, or overvalued.

What is Rosinbomb's fair value?

Fair value for ROSN is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value ROSN?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from ROSN's most recent reported fundamentals.

ROSN - Rosinbomb

Price: -- --

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 50% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 389.9% above fair value

Current Price $0.02

Bear Case $0.00 82.9% downside ($0.00 - $0.02) / $0.02 = -82.9% $0.00 × 27x P/E

Fair Value $0.00 79.6% downside ($0.00 - $0.02) / $0.02 = -79.6% $0.00 × 32x P/E

Bull Case $0.00 76.3% downside ($0.00 - $0.02) / $0.02 = -76.3% $0.00 × 38x P/E

Adjust Assumptions

P/E Multiple

32.2x

Adjusted EPS

0.0$

Key Value Driver

Normalized P/E multiple (32x base case)

Implied Market Multiple 158.0x

Plain-Language Summary

Applying a 32x P/E to adjusted EPS of $0.00, the base-case value is $0.00 per share.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples